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Cardiac K channels are critical determinants of cardiac excitability. In hypertrophied and
failing myocardium, alterations in the expression and activity of voltage-gated K channels
are frequently observed and contribute to the increased propensity for life-threatening
arrhythmias. Thus, understanding the mechanisms of disturbed K channel regulation in
heart failure (HF) is of critical importance. Amongst others, Ca/calmodulin-dependent
protein kinase II (CaMKII) has been identiﬁed as an important regulator of K channel activity.
In human HF but also various animal models, increased CaMKII expression and activity has
been linked to deteriorated contractile function and arrhythmias. This review will discuss
the current knowledge about CaMKII regulation of several K channels, its inﬂuence on
action potential properties, dispersion of repolarization, and arrhythmias with special focus
on HF.
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INTRODUCTION
Heart failure (HF) is a leading cause of death in western countries
(United States and Europe), (Neumann et al., 2009; Go et al., 2012;
Nichols et al., 2013) but also in developing countries like China
(Hu et al., 2012). Morbidity in HF is characterized by contrac-
tile dysfunction and an increased propensity for arrhythmias (Luo
andAnderson,2013). Both are known consequences of the electro-
mechanical remodeling of the cardiomyocyte. It is well established
that reduced expression of K channels in hypertrophied and fail-
ing myocardium (Kääb et al., 1996) can lead to action potential
(AP) prolongation, which is known to be pro-arrhythmogenic.
Moreover, AP prolongation also leads to greater systolic Ca entry
through voltage-gated L-type Ca channels (CaV1.2) and impairs
the Ca export function of cardiac Na/Ca exchange (NCX, Bers,
2002a), which results in cytosolic Ca overload and dramatically
impairs diastolic contractile function (Figure 1).
Thus, understanding the mechanisms that are involved in the
regulation of cardiac K channel expression and function in HF
could greatly improve patient treatment.
Ca/calmodulin-dependent protein kinase II (CaMKII) has been
identiﬁed as an important regulator of ion channels and trans-
porters involved in cardiac excitation–contraction coupling under
physiological but also pathophysiological conditions (Maier and
Bers, 2007). Increased CaMKII expression and function was found
in HF and is linked to contractile dysfunction and arrhyth-
mias. Interestingly, there is substantial evidence that CaMKII is
also involved in K channel regulation (Nerbonne, 2011). This
review will discuss CaMKII-dependent regulation of several car-
diac potassium channels and its signiﬁcance for arrhythmogenesis
and contractile function in HF.
K CHANNELS ARE IMPORTANT REGULATORS OF CARDIAC
EXCITABILITY
The cardiac AP is initiated by activation of voltage-gated Na chan-
nels (NaV1.5). The resulting Na current (INa) leads to a rapid
depolarization, i.e., the AP upstroke (phase 0; Bers, 2002b). The
upstroke is limited by inactivation of INa and voltage-dependent
activation of transient outward K channels (KV4.2, KV4.3, and
KV1.4 generating Ito). Ito activation results in an early repo-
larization (notch, phase 1), thus setting the voltage plateau of
the AP. Activation of L-type Ca channels generates a depolar-
izing Ca current (ICa) that stabilizes the membrane potential
during the plateau phase (phase 2). Repolarization in phase 3
is mainly caused by activation of delayed rectifying K chan-
nels [hERG (KCNH2), Kv7.1 (KCNQ1), and Kv1.5 (KCNA5)
responsible for IKr, IKs, and IKur, respectively]. Additionally,
activation of inward rectifying K channels (Kir2.x, generat-
ing IK1) contributes to late phase repolarization. The resting
membrane potential (phase 4) is stabilized by IK1, but ion con-
ductance in phase 4 is also inﬂuenced by the Na/K-ATPase
and NCX.
In pacemaker cells, the absence of a stabilizing IK1 is responsible
for a more positive resting membrane potential (Cho et al., 2003).
The non-speciﬁc cation current If (channel protein HCN) can
thus generate diastolic depolarization leading to the generation of
APs (Bers, 2002b).
Several mechanisms of arrhythmogenesis involving K channels
have been described. Reduced function of Kv7.1 and hERG are the
hallmark of congential long QT syndrome 1 and 2, respectively
(Brenyo et al., 2012). A smaller IKs and IKr results in prolonged
repolarization that is associated with torsade de pointes and
sudden cardiac death (Roden, 2008). The underlying arrhyth-
mic mechanisms involve increased triggered activity due to early
afterdepolarizations (EADs) or reentry due to increased spatial
heterogeneities in repolarization (see below). Recently, a muta-
tion of an ATP-sensitive K channel (Medeiros-Domingo et al.,
2010) has been identiﬁed in a patient with early repolarization
syndrome, which is characterized by a prominent J wave on the
ECG (see below) and is associated with an increased risk of ven-
tricular ﬁbrillation (VF) and cardiac death (Tikkanen et al., 2009).
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FIGURE 1 | Electro-mechanical remodeling in ventricular myocytes in
HF. Normal currents are indicated by black arrows, while changes in HF
are indicated by red arrows and changes in size to indicate an increase
or decrease in current density. CaMKII effects on potassium currents are
indicated by bar-headed lines (in this ﬁgure only CaMKII effects on K
currents are shown, for a detailed review of CaMKII effects refer to
Maier and Bers, 2007). Decreased expression and function of
repolarizing K currents (Ito, IKr, IKs, IK1), for instance due
CaMKII-mediated effects leads to prolongation of the AP duration. This
can result in greater systolic Ca entry through voltage-gated Ca
channels, but also Na entry through increased late Na current (via
voltage-gated Na channels, Shryock et al., 2013). Increased cytosolic Na
concentrations, a feature also observed in HF (Pieske et al., 2002),
together with prolonged AP duration also impairs the Ca export function
of cardiac Na/Ca exchanger (Bers, 2002a), which further aggravates the
net gain in cytosolic Ca. In the face of a reduced function of the
sarcoplasmic reticulum (SR) Ca ATPase in HF (SERCA; Hasenfuss,
1998), this Ca remains in the cytosol thereby dramatically impairing
diastolic function. Moreover, increased depolarizing currents (Na and Ca
currents) during the plateau phase of the AP could lead to early
afterdepolarizations (EADs), while increased diastolic SR Ca leak through
ryanodine-receptor 2 (RyR) facilitates delayed afterdepolarizations (DADs).
It was shown that this mutation results in gain of function in
KATP (Medeiros-Domingo et al., 2010), consequently resulting in
increased transmural heterogeneity of repolarization (see below).
Interestingly, besides rare congenital disease, altered K chan-
nel function has also been described for HF. It was shown that
decreased IK1 and Ito density could lead to AP prolongation (Kaab
et al., 1998).
Increased triggered activity is an important consequence of
prolonged repolarization. The longer phase 2 of the AP results
in reactivation of Ca channels that generate a depolarizing current
possibly resulting in an EAD and ultimately leading to a triggered
AP (Weiss et al., 2010). On the other hand, K channels have been
also been shown to be involved in the generation of delayed after-
depolarizations (DADs) that are a consequence of cytosolic and
sarcoplasmic reticulum (SR) Ca overload. The latter causes an
increased propensity of spontaneous ryanodine-receptor (RyR)
activation leading to a depolarizing inward NCX current (Kääb
et al., 1996). Interestingly, this inward NCX current is more likely
to induce DADs if IK1 is functionally downregulated, causing an
unstable resting membrane potential (Dhamoon and Jalife, 2005).
Differential K channel expression across the ventricular wall
is the basis for transmural dispersion of repolarization (TDR,
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Antzelevitch and Fish, 2001). Physiologically, the endocardial
myocyte has a smaller Ito amplitude compared to the epicar-
dial myocyte. This, together with increased depolarizing currents,
contributes to a more positive AP plateau and a longer AP dura-
tion in the endocardial compared to the epicardial myocyte.
The result is a physiological TDR that also determines the
positive T wave on the surface ECG. However, under patho-
physiological conditions this ﬁne balanced regional difference
in K channel function can be substantially altered. A pref-
erential shortening of the epicardial AP by enhanced Ito, for
instance, together with a preferential prolongation of the endo-
cardial AP by enhanced late INa and minor changes in the small
Ito would increase the TDR. While a TDR increase in phase 1
and 2 of the AP results in the occurance of a J wave (posi-
tive deﬂection at the QRS-ST junction; Yan and Antzelevitch,
1996), increased TDR in phase 3 and 4 can cause abnormal
T waves. If the increase in TDR in phase 3 and 4 reached
a threshold, abnormal electrical activity would ﬁnd excitable
myocytes, resulting in reentry and leading to torsade de pointes
(Yan and Antzelevitch, 1996). Computational modeling of a
rabbit ventricular myocyte overexpressing CaMKII was used to
investigate the importance of the expression level of Ito for AP
duration (Grandi et al., 2007). If 100% Ito expression was used
( = epicardial myocytes), CaMKII overexpression resulted in a
shortening of theAP durationmainly due to a CaMKII-dependent
enhancement of Ito. With 10% Ito expression ( = endocardial
myocytes), however, AP duration increased because CaMKII-
enhanced late INa and L-type Ca current outweighed the effect on
the smaller Ito. The mechanisms by which CaMKII alters potas-
sium channel expression and function will be discussed in this
review.
CaMKII AND HF
Calcium-Calmodulin-dependent kinase II is a serine/threonine
kinase that can regulate multiple ion channels and transporters
including K channels (see below). Currently, four isoforms and up
to 30 splice-variants of the serine/threonine CaMKII have been
identiﬁed, with CaMKIIδ as the predominant cardiac isoform
(Maier and Bers, 2007). CaMKII contains an N-terminal cat-
alytic kinase-domain with an ATP-binding site as well as substrate
binding sites. Adjacent to the catalytic subunit, an autoregulatory
domainwith a calmodulin (CaM)-binding site and important reg-
ulatory threonine (T287, T306, T307) and methionine residues
(M281/282) precedes the C-terminal association-domain, which
is critical for the assembly of the holoenzyme. In vivo, self-
association of CaMKII holoenzymes forms two ring-like CaMKII-
hexamers which are stacked on top of each other (dodecameric
conﬁguration; Rellos et al., 2010). CaMKII is activated by bind-
ing of a Ca/CaM complex to its autoregulatory domain, resulting
in conformational changes which expose the catalytic subunit,
enabling ATP and substrate binding. An important substrate is
the autoregulatory domain of an adjacent subunit, resulting in
inter-subunit phosphorylation at T287 (auto-phosphorylation).
The latter enables CaM-independent activity after the dissociation
of Ca/CaM (Maier and Bers, 2007). Novel alternative activation
pathways have also been described involving oxidation or glyco-
sylation at M281/282, both of which result in Ca-independent
activity similar to auto-phosphorylation (Erickson et al., 2008,
2013).
CaMKII has been associated with HF development. In human
HF, expression and activity of CaMKII is increased (Hoch et al.,
1999; Kirchhefer et al., 1999; Ai et al., 2005). Moreover, CaMKIIδ-
transgenicmice developHFwith increasedAPduration, disturbed
Ca handling, and are prone to ventricular arrhythmias (Maier,
2003; Wagner et al., 2011). In contrast, transgenic CaMKII inhi-
bition or CaMKII knockout prevents cardiac remodeling and HF
development after myocardial infarction or increased afterload
(Zhang et al., 2005; Backs et al., 2009; Ling et al., 2009).
TRANSIENT OUTWARD K CURRENT
Ito is generated by a pore-forming α-subunit with six transmem-
brane segments (S1–S6). Accessory β-subunits can associate with
this α-subunit (Figure 2A, Niwa and Nerbonne, 2010). In their
either homologous or heterologous tetrameric assembly, the sub-
units’ S5 and S6 segments face each other to form the pore, while
segment S4 senses voltage (Snyders, 1999; Niwa and Nerbonne,
2010). Ito is critical for the early repolarization (“notch”) imme-
diately following the upstroke in phase 0 of the cardiac AP. There
are at least two components of Ito generated by different channel
isoforms, that can be distinguished according to their recovery
and inactivation kinetics (Figure 2B; Brahmajothi et al., 1999).
The fast component (Ito,fast) inactivates and recovers with time
constants (τ) of less than 100 ms, whereas the slow component
(Ito,slow) inactivates with τ of about 200 ms and recovers with
τ ranging from hundreds of milliseconds up to several seconds
(Brahmajothi et al., 1999; Xu et al., 1999).
In human, rat, and canine tissue, Ito is generated mostly by
the rapidly recovering channel population Kv4.3 (KCND3, Dixon
et al., 1996). In a tachycardia-induced canine model of HF, a
reduced ventricular Kv4.3 protein expression has been reported
alongwith decreased Ito density (Zicha et al., 2004). It has also been
shown that Kv4.3 expression is signiﬁcantly reduced in human
HF and that this is associated with a signiﬁcant decrease in Ito
density (Kaab et al., 1998; Zicha et al., 2004). Reduced Ito density
is known to contribute to AP prolongation and prolonged QT
intervals (Barry et al., 1998).
Despite this important role of Kv4.3 for Ito in human car-
diac tissue, many animals species show a rather heterogeneous
channel population comprised of Kv4.3, Kv1.4 (KCNA4), Kv4.2
(KCND2), and accessory KChIP subunits. In these species, Ito
can be separated into the fast and slow component with varying
relative contributions to total Ito. In rabbit and mouse cardiac
myocytes, for instance, Kv1.4 has been shown to be responsible
for the slow component while a complex of Kv4.2, Kv4.3, and
KChIPs is responsible for the fast component (Niwa and Ner-
bonne,2010). Similar to the dogmodel of HF, tachycardia-induced
HF in rabbits showed reduced total Ito density while AP dura-
tion was prolonged (Rose, 2005). Interestingly, mRNA levels of
Kv1.4 and Kv4.2, as well as KChIP2, were signiﬁcantly reduced,
while Kv4.3 mRNA was unchanged. Protein expression of Kv4.2
and KChIP2 was signiﬁcantly reduced, though Kv4.3 and Kv1.4
were unchanged (Rose, 2005). In a TNF-α-overexpressing mouse
model of HF, Ito,fast density and Kv4.2 protein expression was sig-
niﬁcantly reduced (Petkova-Kirova, 2006). Other mouse models
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FIGURE 2 | Structure and function of K channels. (A) Structure of
voltage-gated K channel α-sunbunit (Kv) with six transmembrane segments
(S1–S6). The S5–S6 segments face each other to form the central pore. The
P-loop between the S5 and S6 segments acts as an ion conductance pathway
and its signature motif G(Y/F)G functions as a K ion selectivity ﬁlter. Segment
S4 senses voltage and moves outward during cell membrane depolarization
resulting in conformational changes which open the pore. (B)There are two
current components of Ito generated that can be distinguished according to
their inactivation kinetics. Ito,fast inactivates with time constants (τ) of less
than 100 ms, whereas the Ito,slow inactivates with τ of about 200 ms.
(C) CaMKII can bind to Kv4.3 and phosphorylate serine 550 of its C terminus,
which leads to altered current kinetics. SAP97 can also bind to Kv4.3 [at its
Ser-Ala-Leu (SAL) segment] and possibly mediates the CaMKII-Kv4.3
interaction. (D) Inward rectifying potassium channels are formed by four
α-subunits containing only two transmembrane segments (M1–M2) with a
central P-loop as ion conductance pathway.
of HF exhibited similar reductions in Ito density and increased AP
duration (Knollmann et al., 2000; Mitarai, 2000).
The differential regulation in the expression and function of
the various channel isoforms underlying Ito suggests that the two
components Ito,fast and Ito,slow are functionally and structurally
independent ion currents.
CaMKII-DEPENDENT REGULATION OF Ito EXPRESSION
CaMKII has been shown to inﬂuence the expression of channel
isoforms underlying Ito. In mice overexpressing CaMKIIδ, it was
shown that total Ito density is signiﬁcantly reduced (Wagner et al.,
2009). This reduction was secondary to a reduced expression of
Kv4.2 with reduced Ito,fast and accompanied by a prolongation
of the cardiac AP (Wagner et al., 2009). In contrast, expression
of Kv1.4 and Ito,slow were increased but this increase could not
fully compensate the reduction in Ito,fast (Wagner et al., 2009).
Interestingly, chronic CaMKII inhibition in mice by transgenic
expression of the speciﬁc CaMKII inhibitory peptide AC3-I, a
derivative of CaMKII substrate autocamtide-3, resulted in an
increase in Ito,fast and shorter AP duration. On the other hand,
the increase in Ito density was absent in crossbred mice express-
ing AC3-I but lacking phospholamban (PLN; Li et al., 2006).
Since mice overexpressing CaMKIIδ also develop HF and chronic
CaMKII inhibition may also affect the SR, it is not clear whether
these changes are CaMKII-speciﬁc or secondary to remodeling or
interference with other pathways. This is supported by the fact
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that short-term overexpression of CaMKIIδ in rabbit myocytes
increases Ito (Wagner et al., 2009). Similary, in silico experiments
with simulated CaMKII overexpression in rabbit myocytes also
led to an increase in Ito along with faster Ito,slow recovery from
inactivation (Grandi et al., 2007). Furthermore, Li et al. (2006)
found no change in the expression of pore-forming subunits
Kv4.2/Kv4.3 underlying increased Ito but only a downregulation
of the accessory subunit KChIP2, suggesting that the regulation
of Ito is complex, involving many interacting partners. In this
respect it is not surprising that Kv4.3 and Kv4.2 form large macro-
molecular complexes with other proteins such as diaminopeptidyl
transferase-like protein 6 (DPP6) and Eps15 homology domain-
containing protein 4 (EHD4) (Marionneau et al., 2011). Recent
evidence suggests that these proteins are important for endocyto-
sis, vesicular recycling and trafﬁcking (Cai et al., 2013). Perhaps
more importantly, it has been shown that KChIP1 clamps two
adjacent Kv4.3 α-subunits together via two contact interfaces that
interact with the N-termini of Kv4.3 (Pioletti et al., 2006; Wang
et al., 2006b). This stabilizes KV4.3 tetramers and also exerts an
inﬂuence on current kinetics with current density being increased,
inactivation slowed, and recovery from inactivation enhanced
(Wang et al., 2006b). In addition, KChIP1 has been shown to
be essential for proper Kv4 trafﬁcking to the membrane (Cui et al.,
2008).
More evidence that the downregulation of Kv4 in HF after
CaMKII overexpression may be secondary and not directly
mediated by CaMKII is derived from experiments investigating
the interaction of the MAGUK (membrane-associated guanylate
kinase) protein SAP97 with Kv4.
In neurons, the interaction of the C-terminal Ser-Ala-Leu
(SAL)-sequence of Kv4.2 with SAP97 has been shown to be crucial
for trafﬁcking of Kv4.2 to the synaptic membrane (Gardoni et al.,
2007). Interestingly, this trafﬁckinghas been shown tobe enhanced
by CaMKII phosphorylation of SAP97 at Serin-39 (Gardoni et al.,
2007). Furthermore, it was shown in cardiac myocytes that
Kv4.2/Kv4.3 channels form complexes with SAP97 and CaMKII
(El-Haou et al., 2009). In the same publication, suppression of
SAP97 in rat atrial myocytes via shRNA led to a decrease in Ito,
whereas SAP97 overexpression resulted in enhanced Ito. More-
over, expression of Kv4.3 lacking the C-terminal SAL-sequence or
SAP97 silencing via shRNA abolished the co-precipitation with
CaMKII (El-Haou et al., 2009). Also, inhibition of CaMKII with
autocamtide-2 related inhibitory peptide (AIP) resulted in reduced
Ito and the inhibition was more pronounced after SAP97 over-
expression (El-Haou et al., 2009). Interestingly, recent evidence
suggests that SAP97 is downregulated in patients with dilated
cardiomyopathy (Szuts et al., 2013).
CaMKII-DEPENDENT REGULATION OF Ito GATING
The ﬁrst evidence for a CaMKII-dependent regulation of cardiac
potassium channel gating came from a study investigating human
atrial myocytes (Tessier et al., 1999). The myocytes were isolated
fromdonorswith either chronic atrial dilationor chronic atrial ﬁb-
rillation (AF). Patch–clamp experiments showed that inactivation
of Ito was accelerated by CaMKII inhibition with either KN-93
or AIP (Tessier et al., 1999). Moreover, Tessier et al. (1999) also
showed an increased expression level of CaMKII in the atrium
of donors with chronic atrial dilation or chronic AF. More evi-
dence for CaMKII regulating Ito came from experiments using
transgenic mice overexpressing CaMKIIδc and also short-term
CaMKIIδc overexpression in rabbit myocytes. It was shown that
the recovery from inactivation of Ito,fast and Ito,slow was enhanced
by CaMKII overexpression (Wagner et al., 2009). This enhance-
ment could be blocked by acute CaMKII inhibition suggesting
that this was not secondary to HF development (Wagner et al.,
2009). The underlying mechanism of CaMKII-dependent regula-
tion of Ito may involve direct CaMKII-dependent phosphorylation
of Kv4.2 at serine 438/459, and of Kv1.4 at serine 123 (Roeper,
1997; Varga, 2004). Patch-clamp experiments in HEK-293 cells
transfected with Kv4.3 showed that addition of autothiophospho-
rylated (pre-activated) CaMKII slowed Ito inactivation consistent
with the results obtained by Tessier et al. (1999) and enhanced
recovery from inactivation (Sergeant, 2005). Conversely, HEK
cells treatedwithCaMKII-inhibitorKN-93orCaMKII-inhibitory-
peptide displayed signiﬁcantly accelerated current inactivation
and slowed recovery from inactivation (Sergeant, 2005). More-
over, if the C-terminal Kv4.3 mutant (serine 550 to alanine) was
expressed, Ito inactivation was enhanced and Ito recovery was
slowed (Sergeant, 2005). Neither addition of autothiophospho-
rylated CaMKII nor dialysis of CaMKII inhibitors could affect
Ito recovery in HEK cells expressing this Kv4.3 S550A mutant
(Sergeant, 2005), supporting the concept that the C-terminus of
Kv4.3 is a hotspot for CaMKII-dependent association and regula-
tion of Ito,fast (Figure 2C). Further evidence for a direct regulation
of Ito,fast by CaMKII comes from studies in rat ventricular myocyte
lysates showing that CaMKII co-immunoprecipitates with both
Kv4.3 and Kv4.2 (Colinas, 2006), and inhibition of CaMKII with
KN-93 resulted in a signiﬁcant acceleration of Ito inactivation
even through recovery from inactivation was unaffected (Colinas,
2006).
Interestingly, this CaMKII-dependent enhancement of Ito may
also be important for reactive oxygen-species (ROS) induced
arrhythmogenesis. ROS are known to oxidize and activate CaMKII
(Erickson et al., 2008; Wagner et al., 2011) and ROS-induced
arrhythmias are known to be CaMKII-dependent (Wagner et al.,
2011). Recently, it was proposed that ROS-dependent activation of
Ito favors EADs by facilitating ICareactivation (Zhao et al., 2012).
Thus, CaMKIIδc appears to regulate both channel expression
and/or trafﬁcking, but also acutely regulates channel gating prop-
erties. In both cases, acute regulation results in an enhancement of
Ito. In contrast to this, chronic CaMKII overexpression that leads
to HF development results in a reduction of Ito but this appears to
be a secondary effect.
Kv4.3 AS AN IMPORTANT REGULATOR OF CaMKII ACTIVITY
While Kv4.3 is an important target for CaMKII, it may also inﬂu-
ence CaMKII localization and activity. Recently, in HEK-293 cells
transfected with Kv4.3 and His-tagged CaMKII, it was shown that
Kv4.3 binds to CaM-dissociated CaMKII competitively at its CaM
binding site (residues 301 and 307; Keskanokwong et al., 2010).
This binding was independent from the auto-phosphorylation
status of CaMKII, since both constitutively active (T-287D) or
inactive (T-287A) CaMKII-mutants could also bind to Kv4.3
(Keskanokwong et al., 2010).
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Since the CaMKII inhibitor KN93 also binds CaMKII at the
CaM binding site (Sumi, 1991), it is conceivable that KN-93 dis-
turbs the interaction of CaMKII and Kv4.3. Consistent with this
idea, Keskanokwong et al. showed that co-puriﬁcation of Kv4.3
andCaMKII is abolished upon addition of KN-93. Furthermore, it
was shown that application of the Kv4.3 blocker 4-aminopyridine
(4-AP) disturbes the co-puriﬁcation of CaMKII and Kv4.3 in
HEK-293 cells, while CaMKII auto-phosphorylation is increased
(Keskanokwong et al., 2010). Similarly, increased CaMKII activity
was found in guinea pig ventricular myocytes treated with 4-AP
(Wang et al., 2006a). Moreover, 4-AP-induced blockade of Kv4.3 in
HEK-293 cells has been shown to result in increased apoptosis and
enhanced CaMKII-auto-phosphorylation, while the authors were
able to prevent apoptosis by inhibition of CaMKII with KN-93
(Zhang et al., 2012).
This suggests that Kv4.3 may function as a reservoir for inac-
tive CaMKII-units and exert an inﬂuence on CaMKII activation
levels (Figure 2C). In accordance with this hypothesis, in vivo
overexpression of Kv4.3 in mouse ventricular myocardium via
multiple-site virus injection decreased the level of phosphory-
lated CaMKII,while CaMKII expression was not affected. CaMKII
bound to Kv4.3 was also shown to be protected from activation
by systolic Ca transients (Keskanokwong et al., 2010). The Kv4.3-
CaMKII interaction may also be important for the regulation of
other CaMKII target proteins. For instance, it was shown that
blockade of Kv4.3 with 4-AP results in increased ICa that could be
blocked by buffering cytosolic Ca with BAPTA or application of
AIP (Wang et al., 2006a).
As previously mentioned, Kv4.3 is downregulated in HF (Kaab
et al., 1998) while CaMKII is upregulated (Hoch et al., 1999). The
CaMKII-Kv4.3 interaction may thus be severely altered in HF, con-
tributing to higher CaMKII activity. In this context, the previously
mentioned role for SAP97 in the regulation of Kv4.3 expression
and Kv4.3-CaMKII interaction may be important. Downregula-
tion of SAP97 in HF (Szuts et al., 2013) may underlie reduced
Kv4.3 and may contribute to increased CaMKII activity.
INWARDLY RECTIFYING CURRENT IK 1
In contrast to the voltage-gated K channels, inwardly rectifying
potassium channels [Kir2.1 (KCNJ2), Kir2.2 (KCNJ12), Kir2.3
(KCNJ4), and Kir2.4 (KCNJ14)] are formed by four α-subunits
containing only two transmembrane segments (M1–M2) with a
central P-loop but without a voltage-sensor (Figure 2D; Hibino
et al., 2010). The main characteristic of this class of potassium
channels is inward rectiﬁcation, which features a strong potassium
conductance during hyperpolarization, but a decrease in ion con-
ductance upon depolarization due to blockade of the pore by Mg,
Ca and cell membrane polyamines (Matsuda et al., 1987; Matsuda
and Cruz, 1993; Hibino et al., 2010).
This peculiar inward rectifying property of the Kir2.x channels
that generate IK1 renders these channels important stabilizers of
the resting membrane potential by neutralizing resting inﬂux of
positive ions (Fauconnier et al., 2005). In addition, Kir2.x channels
also contribute to late-phase (phase 4) repolarization (Dhamoon,
2004; Dhamoon and Jalife, 2005; Fauconnier et al., 2005).
In sinoatrialmyocytes, the expressionof channels forming IK1 is
notably reduced, which allows for an unstable resting membrane
potential that can be depolarized by If , thus inducing diastolic
depolarization (Bers, 2002b).
There is evidence that Kir2.x isoforms can assemble as homo-
or heterotetrameres (Zobel et al., 2003). The functional character-
istics of IK1 depend very much on the Kir isoforms that comprise
IK1 (Panama et al., 2010), since rectiﬁcation of current at depo-
larized membrane potentials ( > −30 mV) is complete for Kir2.1
and Kir2.2, but incomplete for Kir2.3 (Dhamoon, 2004). There
is great variability in the expression of these isoforms between
left and right ventricle (Warren et al., 2003) but also atrium and
ventricle (Gaborit et al., 2007). Similar to channel subunits gen-
erating Ito, expression of the Kir isoforms appears to be strongly
species-dependent (Jost et al., 2013).
Ca OR CaMKII-DEPENDENT REGULATION OF IK1
IK1 functional expression also seems to be regulated differently
under pathophysiological conditions. It was shown that IK1 den-
sity is reduced in failing rat ventricular myocytes (Fauconnier
et al., 2005). Interestingly, this reduction was attenuated in the
presence of high EGTA (10 mmol/L) and abolished if intracel-
lular Ca was buffered with BAPTA (20 mM; Fauconnier et al.,
2005). Moreover, activation of RyR by application of ryanodine
or FK506 led to a similar reduction of IK1 density in non-
failing wild-type rat ventricular cells and this effect could be
blocked by Ca-buffering with BAPTA (Fauconnier et al., 2005).
Whether this reduction occurs via direct Ca-dependent blockade
of IK1 via the mechanism described (Matsuda and Cruz, 1993) or
mechanisms involving altered expression/trafﬁcking of the under-
lying Kir isoforms is, however, completely unknown. Fauconnier
et al. (2005) also suggested the involvement of protein kinase C
(PKC), since the PKC inhibitor staurosporine antagonized the
effect of ryanodine on IK1. PKC has been shown to phospho-
rylate Kir2.1 at serine 64 and threonine 353, leading to reduced
IK1 in human atrial myocytes (Karle, 2002). On the other hand,
opposite results have recently been shown in canine ventricular
myocytes. Addition of 900 nmol/L Ca in the patch pipette sig-
niﬁcantly increased IK1 current compared to measurements with
160 nM Ca (Nagy et al., 2013). Therefore, the effect of Ca on
IK1 may be species-dependent. Supporting evidence comes from
intact ﬁeld-stimulated (1 Hz) canine right ventricular papillary
muscle. Increasing extracellular Ca from 2 to 4 mmol/L, resulted
in increasedCa transient amplitude and signiﬁcantly shortenedAP
duration. This Ca-dependent AP shortening could be prevented
by inhibition of IK1 using BaCl2. Moreover, BaCl2 preferen-
tially prolonged AP duration at 4 mM [Ca]o vs. 2 mM [Ca]o.
The authors conclude that Ca-dependent enhancement of IK1,
at least in canine myocytes, may be an important contributor
to repolarization reserve and an endogenous negative feedback
mechanism inhibiting the generation of DADs due to high Ca lev-
els (Nagy et al., 2013). Moreover, Nagy et al. (2013) also showed
that CaMKII inhibition with KN-93 abolished the Ca-induced
activation of IK1, suggesting that CaMKII is also involved in IK1
regulation. Supporting evidence for a CaMKII-dependent activa-
tion of IK1 also comes from rabbit ventricular myocytes. Acute
overexpression of CaMKIIδ by adenovirus-mediated gene trans-
fer resulted in a signiﬁcant increase in IK1 density that could
be blocked by addition of CaMKII-inhibitory peptide AIP to
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the pipette (Wagner et al., 2009). In the same, study, trans-
genic CaMKIIδ overexpression in mice that develop HF, however,
resulted in a reduced IK1 density and reduced expression of Kir2.1
(Wagner et al., 2009). Thus, the discrepancy between the stud-
ies showing either increased or decreased IK1 may be due to
species-differences but this remains speculative. In accordance,
mouse ventricular myocytes with transgenic inhibition of CaMKII
showed an increased IK1 and a shorter AP duration without a sig-
niﬁcant change in Kir2.1 and Kir2.2 expression levels (Li et al.,
2006).
Aside from the species, it could also be relevant if the
studied model results in HF. It was shown that SAP97 co-
immunoprecipitates with Kir2.2 in rat hearts (Leonoudakis et al.,
2004). Interestingly, in human dilated cardiomyopathy, the co-
localization of SAP97withKir2.xwas shown to be disturbed (Szuts
et al., 2013). This suggests that a mechanism similar to the above
mentioned Kv4.x-SAP97 interaction may be present. Therefore,
further studies are greatly needed to clarify the importance of Ca
and CaMKII for the regulation of IK1 in different animal models
and in human disease (Table 1).
IK1 AND ARRHYTHMIAS
IK1 is generally regarded as anti-arrhythmic by stabilizing resting
membrane potential. In a canine model of tachycardia-induced
HF, reduced IK1 has been shown to increase the propensity for sud-
den cardiac death and ventricular tachycardia (Kääb et al., 1996).
Also, loss of function mutations in KCNJ2 have been associated
with long QT syndrome (LQT7), in which increased AP duration
and increased propensity for arrhythmias can be observed (Tsuboi
and Antzelevitch, 2006).
On the other hand, contrasting results have been shown
for wild-type Kir2.1 overexpressing mice that have an increased
propensity for ventricular arrhythmias (Noujaim et al., 2006; Piao
et al., 2007) or AF (Li, 2004). Kir2.1 knock-down in mice was
associated with longer AP duration and a reduced incidence of
premature ventricular contractions before and after AV node abla-
tion, reduced arrhythmias due to extracellular hypokalemia, and
a reduced incidence of halothane-induced ventricular tachycardia
(Piao et al., 2007).
This discrepancy may be solved by the fact that both increase
or decrease of IK1 can be pro-arrhythmic if there is a substantial
spatial heterogeneity in the functional expression proﬁle (Sekar
et al., 2009). In accordance with this, gain-of-function mutations
in KCNJ2 can result in short QT syndrome (SQT3), which is also
pro-arrhythmogenic (Brenyo et al., 2012).
DELAYED RECTIFYING K CHANNELS
The three channels Kv1.5 (KCNA5), hERG (KCNH2), and Kv7.1
(KCNQ1) comprise the group of the delayed rectifying K chan-
nels. They generate IKur (ultra rapid), IKr (rapid), and IKs (slow),
respectively. Together, they are important currents for phase 3
repolarization.
IKur is only present in atrialmyocardium. In chronic humanAF,
it was shown that AP duration is reduced, possibly contributing
to the arrhythmogenic mechanisms (Wettwer, 2004). Evidence for
a role of Kv1.5 in AF came from a study investigating pharma-
cological Kv1.5 inhibition in a canine model of AF (Regan et al.,
2007). They could show that AF terminates if Kv1.5 is inhibited.
Furthermore, SAP97 was reported to co-immunoprecipitate with
Kv1.5 (Murata et al., 2001) resulting in increased IKur (Godreau
et al., 2002; Eldstrom et al., 2003).
Since SAP97 and CaMKII have been shown to interact
(El-Haou et al., 2009), CaMKII expression is increased in AF
(Tessier et al., 1999; Neef et al., 2010), and given the similarities
between SAP97-dependent Kv4.3 and Kv1.5 regulation (Tessier
et al., 1999; Godreau et al., 2002; El-Haou et al., 2009), it seems
tempting to speculate that CaMKII could also regulate Kv1.5.
Interestingly, in human atrialmyocytes it was shown thatCaMKIIδ
is especially localized at intercalated disks, the region where Kv1.5
is also located (Tessier et al., 1999). Furthermore, Tessier et al.
(1999) showed that selective inhibition of CaMKII with KN-93
or AIP reduced the amplitude of the sustained component of out-
ward K current (Isus), whereas inhibition of phosphatases with
okadaic acid increased Isus (Tessier et al., 1999; Tessier, 2001). This
Isus is regarded as mainly generated by Kv1.5 (Fedida et al., 1993),
suggesting that CaMKII, possibly by phosphorylation, regulates
Kv1.5 (Tessier et al., 1999).
Besides IKur, other K currents may also be involved in AF. IK1,
for instance, has been shown to be upregulated in AF possibly
contributing to shortening of AP duration (Dobrev and Ravens,
2003).
IKs is comprised of the pore-forming α-subunit Kv7.1, but
also the auxiliary β-subunit KCNE1 (Ruscic et al., 2013). Loss-
of-function mutations in KCNQ1 are linked to an increase in
AP duration associated with long QT-syndrome type I, whereas
gain-of-function mutations in KCNQ1 are associated with short
QT-syndrome (SQT2) (Brenyo et al., 2012) and familial AF (Chen
et al., 2003). Additionally, loss-of-function mutations in KCNE1
have been associated with long QT-syndrome 5 (Splawski et al.,
1997), which points out the important role of KCNE1 for the gen-
eration of IKs. Indeed it has been shown that KCNE1 is important
in slowing down the movement of the voltage-sensor S4 of Kv7.1
upon depolarization, thus explaining the slow activation kinet-
ics of IKs (Ruscic et al., 2013). Similar mechanisms may very well
regulate other voltage-gated channels and underlie their distinct
activation kinetics.
Interestingly, co-immunoprecipitation experiments in yeast
cells expressing wild-type Kv7.1 or mutated Kv7.1 with truncated
α-helices showed that calmodulin can bind to the C-terminus of
Kv7.1 (Shamgar, 2006). This IQ-motif appears to be a hot spot
for mutations: yeast 2-hybrid experiments indicated that KCNQ1
mutations A371T and S373P, which are associated with LQTS, lose
their calmodulin-Kv7.1 interaction.
Moreover, agarose-pulldown assays in HEK-293 cells revealed
that LQTS-associated Kv7.1 mutants W392R, S373P, and A371T
bound signiﬁcantly less calmodulin than wild-type Kv7.1 (Sham-
gar, 2006). This disturbed calmodulin- Kv7.1 interaction may be
important for channel expression. Cell surface expression exper-
iments with biotinylated channel proteins showed that mutants
with impaired CaM-binding are signiﬁcantly less expressed than
wild-type Kv7.1 (Shamgar, 2006). Interestingly, overexpression of
calmodulin in HEK-293 cells either expressing wild-type Kv7.1 or
mutant S373P showed signiﬁcant increases in Kv7.1 (5x) as well as
S373P (100x) cell surface and protein expression, which highlights
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the important role of calmodulin for IKs assembly and cell surface
expression (Shamgar, 2006).
In addition, theCaM-Kv7.1 interactionmay also be relevant for
the regulation of IKs gating. Patch-clamp experiments of inside-
out membrane from Xenopus oocytes showed that application of
calmodulin antagonistW7 signiﬁcantly reduced current density of
Kv7.1/KCNE1,while an increase inCa signiﬁcantly shifted voltage-
dependence of channel activation toward more hyperpolarized
membrane potentials (Shamgar, 2006).
Thus, the interaction of calmodulin and Kv7.1 appears to be
critical for expression and function of IKs, with the intriguing pos-
sibility that regulatory mechanisms could also involve some form
of CaMKII interaction with calmodulin and Kv7.1 or KCNE1.
ATP-SENSITIVE POTASSIUM CURRENT KATP
The ATP-sensitive potassium current KATP, comprising of Kir6.1
(KCNJ8) and Kir6.2 (KCNJ11) α-subunits, plays an important
role in ischemic preconditioning (Li et al., 2007). KATP can be
a substrate for CaMKII: in mice expressing CaMKII-inhibitory
peptide AC3-I, an increased KATP current density has been shown
along with an increase in the sarcolemmal Kir6.2 membrane
surface expression (Li et al., 2007). Also, recent evidence from
pancreatic β-cells suggests that Kir6.2 can be phosphorylated by
CaMKII at threonine 224 (Kline et al., 2013). Co-expression of
CaMKII and Kir6.2 in COS-cells resulted in a decreased KATP
current.
The signiﬁcance of KATP in HF and arrhythmogenesis is still
largely unknown. There is evidence suggesting that KATP-channel
opening with cromakalim produces more stable ventricular
arrhythmias (Quintanilla et al., 2013). In addition, Langendorff-
perfused canine failing hearts with induced VF showed an
increased rate of spontaneousVF termination, if KATP was blocked
with glibenclamide (Taylor et al., 2012). Also, recently, a mutation
in cardiac Kir6.1 that is associated with gain of function has been
identiﬁed in a patient with early repolarization syndrome (see
above; Medeiros-Domingo et al., 2010).
On the other hand, KATP-blockade with glibenclamide in non-
failing canine hearts with induced VF delayed the termination of
VF (Taylor et al., 2012). Thus, the role of cardiac KATP and its
regulation by CaMKII has yet to be evaluated.
SUMMARY
While there is increasing evidence for an involvement of CaMKII
in the regulation of K channels, many discrepancies are not yet
understood. These discrepancies result from the great variability in
the expression proﬁle of K channels in different species and disease
models. The greatest evidence so far exists for CaMKII-dependent
regulation of Kv4.x expression, trafﬁcking and function. Most
intriguingly, the Kv4.x macromolecular complex appears to serve
as a hotspot and reservoir for CaMKII, which may have profound
impact on the regulation of various other CaMKII targets like Ca
channels. CaMKII expression and activity has been shown to be
increased in many animal models of HF, but also in human HF.
Increased CaMKII activity has been shown to induce contractile
dysfunction and arrhythmias. Therefore, a more detailed under-
standing of the mechanisms of K channel regulation by CaMKII
is warranted.
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